Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study

PURPOSE: Ilaprazole, the latest proton pump inhibitor, can be used with clarithromycin and amoxicillin as a triple therapy regimen for eradicating Helicobacter pylori. The aim of this study was to evaluate pharmacokinetic drug interactions and safety profiles after coadministration of clarithromycin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Byung Hak, Yoo, Byung Won, Park, Jungsin, Kim, Jung Hye, Lee, Jun Yeon, Shin, Jae Soo, Park, Min Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096703/
https://www.ncbi.nlm.nih.gov/pubmed/29846770
http://dx.doi.org/10.1007/s00228-018-2489-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096703/
https://www.ncbi.nlm.nih.gov/pubmed/29846770
http://dx.doi.org/10.1007/s00228-018-2489-2

Ejemplares similares